A patent infringement action filed by Novartis Vaccines and
Diagnostics, Inc. against Wyeth relating to ReFacto and Xyntha is
pending. The Company acquired Wyeth in 2009.
provides in-depth news coverage of intellectual property lawsuits involving public companies with assets of USD $1 billion or more. Coverage focuses on the infringement of intellectual property rights (including patents, copyrights, trademarks, trade dress, trade secrets, and royalties) and corporate indemnification of intellectual property violations.